IP Library › Granted Patent US 9,923,177
Granted Patent B2
US 9,923,177 · App. 14/827,589 · Granted Mar 20, 2018

Biocompatibility of biomedical energization elements

Inventors: Frederick A. Flitsch (New Windsor, NY); Daniel B. Otts (Fruit Cove, FL); Randall B. Pugh (St. Johns, FL); James Daniel Riall (St. Johns, FL); Adam Toner (Jacksonville, FL)
Assignee: Johnson & Johnson Vision Care, Inc.
H01M2/0202B29D11/00817G02C7/04G02C7/083G02C13/001H01M2/08H01M10/26H01M10/0436H01M2002/0205H01M2220/30H01M2300/0014
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,923,177
App. No.
14/827,589
Granted
Mar 20, 2018
Kind
B2
Abstract

Designs, strategies and methods to improve biocompatibility of energization elements are described. In some examples, the biocompatible energization elements may be used in a biomedical device. In some further examples, the biocompatible energization elements may be used in a contact lens.

Claims (28)

1. A biomedical device comprising:

an electroactive component;

a laminar structure,

a biocompatible battery, wherein the biocompatible battery comprises a plurality of cells wherein each cell comprises:

a first and second current collector;

a cathode;

an anode; and

a cavity containing an electrolyte solution, a separator and the cathode, wherein at least a layer of the laminar structure has a volume removed to form the cavity; and

wherein the biocompatibility of the biomedical device is improved by dividing the battery chemicals into the plurality of cells, each of which comprises only a fraction of the total battery chemicals, and wherein the fraction of the total battery chemicals is isolated from a user by material of the laminate structure.

2. The biomedical device of claim 1 wherein a thickness of the biocompatible battery is less than 1 mm at least along a first dimension of an extent of the biocompatible battery.

3. The biomedical device of claim 1 wherein a thickness of the biocompatible battery is less than 500 microns at least along a first dimension of an extent of the biocompatible battery.

4. The biomedical device of claim 1 wherein a thickness of the biocompatible battery is less than 250 microns at least along a first dimension of an extent of the biocompatible battery.

5. A biomedical device comprising:

an electroactive component;

a laminar structure;

a biocompatible battery, wherein the biocompatible battery comprises a plurality of cells, wherein each cell comprises:

a first and second current collector;

a cathode;

an anode; and

a cavity containing an electrolyte solution, a separator and the cathode, wherein at least a layer of the laminar structure has a volume removed to form the cavity; and

wherein the biocompatibility of the biocompatible battery is improved by formulating a composition of the electrolyte solution to comprise a zinc salt at less than or approximately equal to 10 percent by weight.

6. The biomedical device of claim 5 , wherein the biocompatible battery further comprises:

a sealed encapsulation of the laminar structure, wherein the sealed encapsulation improves the biocompatibility of the biomedical device by decreasing an effusion of the electrolyte to an external environment.

7. The biomedical device of claim 5 , wherein the biocompatible battery further comprises:

a sealed encapsulation of the laminar structure, wherein the sealed encapsulation improves the biocompatibility of the biocompatible battery by decreasing an effusion of water into an internal environment of the biocompatible battery.

8. The biomedical device of claim 5 further comprising:

an encapsulating layer of hydrogel.

9. The biomedical device of claim 8 , wherein the encapsulating layer comprises the hydrogel which comprises zwitterions.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 1, 2015
From: FLITSCH, FREDERICK A.; OTTS, DANIEL B.; PUGH, RANDALL B.; RIALL, JAMES DANIEL; TONER, ADAM
To: JOHNSON & JOHNSON VISION CARE, INC.
Reel/Frame 036703/0580 →
Continuity (2)
Provisional Application 62040178 · Aug 21, 2014
Related Publication 20160056417A1 · Feb 25, 2016